Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Khalid Al Sulaiman, Faisal Alsuwayyid, Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Almutairi, Fahad Alharthi, Laila Carolina Abu Esba, Ohoud Aljuhani & Hisham A Badreldin. (2022) Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature. Journal of Blood Medicine 13, pages 105-111.
Read now
Read now
Kannan Sridharan, Rashed Al Banny, Ali Mohamed Qader, Aysha Husain & Kawther Mohamed Qader. (2020) Health-related quality of life in patients receiving oral anti-coagulants: a cross-sectional study. Expert Review of Cardiovascular Therapy 18:5, pages 309-314.
Read now
Read now
Diana Leh-Ching Ng, Gin-Gin Gan, Chee-Shee Chai, Kok-Han Chee, Kok-Leng Tan, Seng-Beng Tan & Ping-Chong Bee. (2019) Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study. Patient Preference and Adherence 13, pages 1363-1373.
Read now
Read now
Niklas Ekerstad, Göran Östberg, Maria Johansson & Björn W Karlson. (2018) Are frail elderly patients treated in a CGA unit more satisfied with their hospital care than those treated in conventional acute medical care?. Patient Preference and Adherence 12, pages 233-240.
Read now
Read now
Masahisa Arahata & Hidesaku Asakura. (2018) Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities. Clinical Interventions in Aging 13, pages 1675-1690.
Read now
Read now
Articles from other publishers (40)
Niki Gkena, Paraskevi Kirgou, Konstantinos I. Gourgoulianis & Foteini Malli. (2023) Mental Health and Quality of Life in Pulmonary Embolism: A Literature Review. Advances in Respiratory Medicine 91:2, pages 174-184.
Crossref
Crossref
Katherine E Hekman, Calvin L Chao, Courtney E Morgan, Irene B Helenowski & Mark K Eskandari. (2021) Direct oral anticoagulants decrease treatment failure for acute lower extremity deep venous thrombosis. Vascular 30:6, pages 1199-1204.
Crossref
Crossref
Alicia Lorenzo, Patricia Beroiz, Salvador Ortiz, Jorge del Toro, Lucia Mazzolai, Alessandra Bura-Riviere, Adriana Visonà, Peter Verhamme, Pierpaolo Di Micco, Giuseppe Camporese, Teresa Sancho Bueso & Manuel Monreal. (2022) Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry. Frontiers in Medicine 9.
Crossref
Crossref
Diana A Gorog, Ying X Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro, Kurt Huber, Stavros V Konstantinidis, Deirdre A Lane, Francisco Marin, Jonas Oldgren, Tatjana Potpara, Vanessa Roldan, Andrea Rubboli, Dirk Sibbing, Hung-Fat Tse, Gemma Vilahur & Gregory Y H Lip. (2022) Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EP Europace 24:11, pages 1844-1871.
Crossref
Crossref
Glenn N. Levine, John W. McEvoy, James C. Fang, Chinwe Ibeh, Cian P. McCarthy, Arunima Misra, Zubair I. Shah, Chetan Shenoy, Sarah A. Spinler, Srikanth Vallurupalli & Gregory Y.H. Lip. (2022) Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation 146:15.
Crossref
Crossref
Anette Arbjerg Højen, Peter Brønnum Nielsen, Thure Filskov Overvad, Ida Ehlers Albertsen, Frederikus A. Klok, Nanna Rolving, Mette Søgaard & Anne Gulbech Ording. (2022) Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation. Journal of Clinical Medicine 11:19, pages 5970.
Crossref
Crossref
Diana A. Gorog, Ying X. Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro, Kurt Huber, Stavros V. Konstantinidis, Deirdre A. Lane, Francisco Marin, Jonas Oldgren, Tatjana Potpara, Vanessa Roldan, Andrea Rubboli, Dirk Sibbing, Hung-Fat Tse, Gemma Vilahur & Gregory Y. H. Lip. (2022) Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. Thrombosis and Haemostasis 122:10, pages 1625-1652.
Crossref
Crossref
Margaret C. Fang, Alan S. Go, Priya A. Prasad, Hui X. Zhou, Anna L. Parks, Dongjie Fan, Cecilia Portugal, Sue Hee Sung & Kristi Reynolds. (2022) Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thrombosis Research 216, pages 97-102.
Crossref
Crossref
Asishana A. Osho, Philicia Moonsamy, Breanna R. Ethridge, Gregory A. Leya, David A. D’Alessandro, Arminder S. Jassar, Mauricio A. Villavicencio, Serguei I. Melnitchouk, George Tolis, Nathaniel B. Langer, Masaki Funamoto, Selena S. Li, Katia M. Colon, Navyatha Mohan, Joseph J. Locascio, Steven A. Lubitz, Oluwaseun Akeju & Thoralf M. Sundt. (2022) Rationale and Design of the Randomized Controlled Trial of New Oral Anticoagulants Versus Warfarin for Post Cardiac Surgery Atrial Fibrillation. Annals of Surgery 276:1, pages 200-204.
Crossref
Crossref
Samir Khiralla & Christiaan A Meadows. (2022) The Effect of Switching From Warfarin to Novel Oral Anticoagulants on Patients’ Satisfaction and the Travel Burden in a Rural Setting. Cureus.
Crossref
Crossref
Katarzyna Lomper, Maria Łoboz-Rudnicka, Tomasz Bańkowski, Krystyna Łoboz-Grudzień & Joanna Jaroch. (2022) The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation. International Journal of Environmental Research and Public Health 19:9, pages 5355.
Crossref
Crossref
Young-Soo Lee, Yong Seog Oh, Eue-Keun Choi, Alan Koay Choon Chern, Panyapat Jiampo, Aurauma Chutinet, Dicky Armein Hanafy, Prabhav Trivedi & Dongmei Zhai. (2021) Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study. Open Heart 8:2, pages e001745.
Crossref
Crossref
Victoria Speed, Vivian Auyeung, Jignesh P. Patel, Derek Cooper, Stephen Miller, Lara N. Roberts, Raj K. Patel & Roopen Arya. (2021) Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry. Research and Practice in Thrombosis and Haemostasis 5:8, pages e12614.
Crossref
Crossref
Margaret C. Fang, Alan S. Go, Priya A. Prasad, Jin-Wen Hsu, Dongjie Fan, Cecilia Portugal, Sue Hee Sung & Kristi Reynolds. (2021) Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism. Journal of Thrombosis and Thrombolysis 52:4, pages 1101-1109.
Crossref
Crossref
Madhvi Rajpurkar, Ayesha Zia, Angela C Weyand, Ronald Thomas, Sarah H. O'Brien, Lakshmi Srivaths & Peter Kouides. (2021) Management of anticoagulation associated reproductive tract bleeding in adolescent and young adult females - Results of a multinational survey. Thrombosis Research 203, pages 61-68.
Crossref
Crossref
Kazuhiko Kido, Yasir Abdul Ghaffar, James C. Lee, Christopher Bianco, Mikiko Shimizu, Tsuyoshi Shiga & Masayuki Hashiguchi. (2021) Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLOS ONE 16:6, pages e0252549.
Crossref
Crossref
Michela Giustozzi, Luca Valerio, Giancarlo Agnelli, Cecilia Becattini, Eva-Maria Fronk, Frederikus A. Klok, Stavros V. Konstantinides, Maria Cristina Vedovati, Alexander T. Cohen & Stefano Barco. (2021) Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE. European Journal of Internal Medicine 88, pages 43-51.
Crossref
Crossref
Chun-Wei Lee, Ming-En Liu, Tsung-Ming Lee, Rei-Yeuh Chang, Chun-Yao Huang, Yu-Feng Hu & Hung-I Yeh. (2021) Patient satisfaction with dabigatrean and warfarin for stroke prevention in atrial fibrillation: Taiwan PASSION study. Journal of the Chinese Medical Association 84:4, pages 375-382.
Crossref
Crossref
Paolo Zappulla & Valeria Calvi. (2021) Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life. TH Open 05:02, pages e200-e210.
Crossref
Crossref
Elena Ivany & Deirdre A. Lane. (2020) Patient Satisfaction: A Key Component in Increasing Treatment Adherence and Persistence. Thrombosis and Haemostasis 121:03, pages 255-257.
Crossref
Crossref
Vasyl Katerenchuk, Gonçalo S. Duarte, Gonçalo Martins e Pereira, Ricardo M. Fernandes, Joaquim J. Ferreira, Fausto J. Pinto, João Costa & Daniel Caldeira. (2020) Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis. Thrombosis and Haemostasis 121:03, pages 366-382.
Crossref
Crossref
Arianna Magon, Cristina Arrigoni, Marco Moia, Michela Mancini, Federica Dellafiore, Duilio F. Manara & Rosario Caruso. (2020) Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonists. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Anne Packard, Thomas Delate, Kerri Martinez & Nathan P. Clark. (2020) Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thrombosis Research 193, pages 40-44.
Crossref
Crossref
C. Ostrowka, L. Journeau, L. Plaisance, G. Poenou, S.E. Mecherour, H. Helfer & I. Mahé. (2020) Educational diagnosis of patients under oral anticoagulant therapy: Development of a 4-category patient profiling score based on a retrospective study and prospective analysis. JMV-Journal de Médecine Vasculaire 45:4, pages 184-191.
Crossref
Crossref
Thomas Hendriks, Scott McGregor, Shilpa Rakesh, Julie Robinson, Kwok M. Ho & Ross Baker. (2020) Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study. PLOS ONE 15:6, pages e0234048.
Crossref
Crossref
Vivencio Barrios, Carlos Escobar, Juan José Gómez-Doblas, Jaime Fernández-Dueñas, Rafael Romero Garrido, Javier Pindado Rodríguez, Juana Umarán Sánchez, Eduardo Arellano-Rodrigo & Esther Donado. (2020) Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists. Journal of Comparative Effectiveness Research 9:9, pages 615-625.
Crossref
Crossref
C. Roseau, C. Richard, S. Renet, C. Kowal, L. Eliahou, A. Rieutord & M.-C. Chaumais. (2020) Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy. International Journal of Clinical Pharmacy 42:2, pages 685-694.
Crossref
Crossref
Itziar Etxeandia-Ikobaltzeta, Yuan ZhangFrancesca BrundisiniIvan D. Florez, Wojtek Wiercioch, Robby NieuwlaatHousne BegumCarlos A. Cuello, Yetiani RoldanRu ChenChengyi DingRebecca L. MorganJohn J. RivaYuqing ZhangRana CharideArnav Agarwal, Sara Balduzzi, Gian Paolo Morgano, Juan José Yepes-Nuñez, Yasir RehmanIgnacio NeumannNicole SchwabTejan BaldehCody BraunMaría Francisca Rodríguez & Holger J. Schünemann. (2020) Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines. Blood Advances 4:5, pages 953-968.
Crossref
Crossref
Dragos Vinereanu, Dmitry Napalkov, Jutta Bergler-Klein, Bela Benczur, Martin Ciernik, Nina Gotcheva, Alexey Medvedchikov, Pentti Põder, Dragan Simic, Andris Skride, Wenbo Tang, Maria Trusz-Gluza, Jiri Vesely, Tatiana Vishnepolsky & Mirej Vrabec. (2020) Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study). Open Heart 7:1, pages e001202.
Crossref
Crossref
Katherine Bunclark, Michael Newnham, Yi‐Da Chiu, Alessandro Ruggiero, Sofia S. Villar, John E. Cannon, Gerry Coghlan, Paul A. Corris, Luke Howard, David Jenkins, Martin Johnson, David G. Kiely, Choo Ng, Nicholas Screaton, Karen Sheares, Dolores Taboada, Steven Tsui, Stephen John Wort, Joanna Pepke‐Zaba & Mark Toshner. (2020) A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. Journal of Thrombosis and Haemostasis 18:1, pages 114-122.
Crossref
Crossref
Fabienne Witassek, Anne Springer, Luise Adam, Stefanie Aeschbacher, Jürg H. Beer, Steffen Blum, Leo H. Bonati, David Conen, Richard Kobza, Michael Kühne, Giorgio Moschovitis, Stefan Osswald, Nicolas Rodondi, Christian Sticherling, Thomas Szucs & Matthias Schwenkglenks. (2019) Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation. PLOS ONE 14:12, pages e0226730.
Crossref
Crossref
Yaqoob Bhat, Anand Dixit, Amit Mistri, Bhavini Patel, Sadat Haider Quoraishi & James Uprichard. (2019) A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol. BMC Neurology 19:1.
Crossref
Crossref
Bárbara Menéndez-Jándula, José Antonio García-Erce, Clara Zazo & Luis Larrad-Mur. (2019) Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Saima Kishvar Afzal, Syed Shahzad Hasan & Zaheer Ud‐Din Babar. (2019) A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants. British Journal of Clinical Pharmacology 85:12, pages 2652-2667.
Crossref
Crossref
Pierluigi Russo, Giuseppe M.C. Rosano, Giampiero Favato, Tommaso Staniscia & Ferdinando Romano. (2019) Cost-effectiveness of direct acting oral anticoagulants in the prevention of thromboembolic complications. Journal of Cardiovascular Medicine 20:8, pages 500-503.
Crossref
Crossref
Jonathan Gospos & Nijole Bernaitis. (2019) Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia. Journal of Clinical Medicine 8:6, pages 863.
Crossref
Crossref
Mohamed A. Taha, Tristan Lane, Joseph Shalhoub & Alun H. Davies. (2019) Endovenous stenting in chronic venous disease secondary to iliac vein obstruction. Italian Journal of Vascular and Endovascular Surgery 26:2.
Crossref
Crossref
Benjamin F. Tillman, Andras Gruber, Owen J.T. McCarty & David Gailani. (2018) Plasma contact factors as therapeutic targets. Blood Reviews 32:6, pages 433-448.
Crossref
Crossref
Majed S. Al Yami, Hisham A. Badreldin, Abdelhameed H. Mohammed, Ahmed M. Elmubark, Mohammed Y. Alzahrani & Abdulmajeed M. Alshehri. (2018) Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis 46:2, pages 145-153.
Crossref
Crossref
Pierluigi Russo, Giampiero Favato, Giuseppe Rosano, Tommaso Staniscia & Ferdinando Romano. (2018) Adequate Use of Economic Evaluations Based on the Endpoints of a Registrative Clinical Trial: Cost-Minimization Analysis and the Return of the Living Dead. SSRN Electronic Journal.
Crossref
Crossref